THE MINISTRY OF HEALTH – THE MINISTRY OF FINANCE

Joint Circular No.  36/2013/TTLT-BYT-BTC dated November 11, 2013 of the Ministry of Health and the Ministry of Finance amending and supplementing some articles of the Joint Circular No. 01/2012/TTLT-BYT-BTC Circular No. 01/2012/TTLT-BYT-BTC dated January 19, 2012 of the Ministry of Health and the Ministry of Finance guiding bidding of drugs procurement in the medical facilities
Pursuant to the Law No. 34/2005/QH11 dated June 14, 2005 on Pharmacy;
Pursuant to the Law No. 61/2005/QH11 dated November 29, 2005 on Tendering, Law amending and supplementing a number of articles of the Law No. 38/2009/QH12  dated June 19, 2009 concerning capital construction investment;
Pursuant to the Decree No. 79/2006/ND-CP dated August 09, 2006 of the Government, detailing implementation of a number of Articles of the Pharmacy Law, the Decree No. 89/2012/ND-CP dated October 24, 2012, amending and supplementing a number of Articles of Government’s Decree No. 79/2006/ND-CP dated August 09, 2006, detailing implementation of a number of Articles of the Pharmacy Law;
Pursuant to the Decree No. 85/2009/ND-CP dated October 15, 2009 of the Government, guiding implementation of Law on tendering and selection of the building contractors under construction law;
Pursuant to Decree No. 63/2012/ND-CP dated August 31, 2012 of the Government defining the functions, tasks, powers and organizational structure of the Ministry of Health;
Pursuant to Decree No. 118/2008/ND-CP dated November 27, 2008 of the Government defining the functions, tasks, powers and organizational structure of the Ministry of Finance,
The Minister of Health, the Minister of Finance promulgate the Joint Circular amending and supplementing a number of articles of the Joint Circular No. 01/2012/TTLT-BYT-BTC dated January 19, 2012, of the Ministry of Health and the Ministry of Finance guiding the bidding for medicine purchase by medical establishments as follows:
Article 1. To supplement point d, Clause 2, Article 2 as follows:
“d) Medical oxygen.”
Article 2. To supplement Clauses 6 and 7, Article 3 as follows:
“6. Establishments producing medicines satisfying EU-GMP or PIC/s-GMP standard mean medicine producers granted certificate of satisfying EU-GMP or PIC/s-GMP standard or equivalent by competent management agencies of countries participating in EMA or ICH or PIC/s and published on website of the Drug Administration of Vietnam by the Ministry of Health (Drug Administration of Vietnam).
7. Countries participating in ICH include EU countries, Japan, American and countries which are observers of ICH and associated members of ICH’s members, as announced by the Ministry of Health (Drug Administration of Vietnam) based on the list updated by ICH.”